Business Wire

Almirall Launches The Hive, Creating a Novel Collaborative Innovation Hub to Advance Life Sciences and Healthcare

Share

Almirall, a global pharmaceutical company dedicated to medical dermatology, today announced the launch of “The Hive”, a novel scientific research hub located at its R&D centre in Barcelona, Spain. The Hive is designed to foster collaboration among researchers from biotech companies, start-ups, academia, and Almirall’s scientists, creating a unique innovation ecosystem that is aimed at advancing scientific breakthroughs and enhancing research success.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241204100180/en/

From left upper row, to right: Marc Soriano, R&D Project Portfolio and Partnership, Lidia Martín, General Manager of Almirall Iberia, Antonio Gallardo, Jorge Gallardo, Dr. Karl Ziegelbauer, Chief Scientific Officer of Almirall, Meritxell Granell, Director of Institutional Relations, Raquel Yotti, PERTE Commissioner for Vanguard Health, Olga Pané, Consellera de Salut, Lourdes Borrell, Mayoress of Sant Feliu de Llobregat, Salvador Illa, President of the Generalitat de Catalunya, Carlos Gallardo, CEO and President of Almirall, Juan Cruz Cigudosa, Secretary of State for Science, Innovation and Universities, Núria Montserrat, Consellera de Recerca i Universitats, and Jaume Baró, Secretary for Business and Competitiveness of the Department of Business and Employment. (Photo: Business Wire)

The Hive builds on Almirall's open innovation centre, which began operations in 2023 with collaborations with two life science companies. The arrival of two new joiners announced today contribute to the creation of this unique collaboration ecosystem, following the initial partnerships with ZeClinics, a Contract Research Organization (CRO) specializing in genetics research using zebrafish as a model organism, and Centrient Pharmaceuticals, a global leader in sustainable biosynthetic pharmaceutical products.

The initiative was launched today as part of Almirall's 80th anniversary celebrations, bringing together health authorities, representatives from associations, entities, and institutions with whom Almirall closely collaborates to deliver against its commitment to patients, innovation, and the advancement of healthcare. The new joiners at The Hive include ADmit Therapeutics a company focused on the early detection of Alzheimer’s and other neurodegenerative diseases through technology that combines epigenetic and clinical data using machine learning. The most recent addition is Microomics a company specializing in metagenomic analysis using new DNA sequencing technologies (NGS).

"At Almirall, we bring together scientific experts from different disciplines in a collaborative environment as we see the transformative power collaboration has to push the boundaries of science and drive the development of novel solutions. An open innovation ecosystem that fosters this collaboration lays an exceptional foundation for breakthroughs in both scientific discovery and product development. We are proud to lead the way with The Hive, a unique initiative designed to advance science and innovation. By working together, we can address critical unmet needs and deliver meaningful progress in healthcare, ensuring that our innovations make a tangible difference in the lives of patients and their families", stated Dr. Karl Ziegelbauer, Almirall’s Chief Scientific Officer.

80 years of innovation and commitment to patients

Almirall is celebrating its 80th anniversary, marking eight decades of commitment to patients, innovation, and healthcare advancement. To commemorate this milestone, the company hosted an institutional event at its R&D centre in Barcelona, Spain. The event brought together health authorities, partners and institutional representatives, including the President of the Generalitat de Catalunya, Salvador Illa, Juan Cruz Cigudosa, Secretary of State for Science, Innovation, and Universities, María José Alonso, professor of Pharmacy and Pharmaceutical Technology at the University of Santiago de Compostela (USC), and Lourdes Borrell, Mayor of Sant Feliu de Llobregat.

Professor María José Alonso congratulated Almirall for its 80 decades “preserving the value of science and its transfer to industry in the best way, contributing to development and well-being, and elevating scientific value in the development of the Spanish innovative ecosystem, fostering a brighter future for all”.

Almirall was founded in Spain in 1944 with the purpose of giving people access to impactful medicines, a goal that continues to guide the company in its ambition as a leading medical dermatology. Almirall´s heritage, its deep scientific expertise, and the strong partnerships with the dermatology community worldwide are the foundation for its broad portfolio of dermatological treatments. Grounded in science and driven by innovation, the company continuously advances the understanding of skin diseases and provides solutions for even the most complex conditions. Based on this dedication, Almirall has become a leader in medical dermatology in Europe, with a strong portfolio of more than 50 products across different modalities, including topical, systemic, and biologics.

The company has invested 1 billion Euros in R&D in medical dermatology in the last decade which represents a continuous investment of over 12% of its annual net sales in R&D. This investment supports all phases of research conducted at its R&D centre – from discovery to late-stage clinical testing. Almirall’s close partnership with patients and dermatologists positions the company as a trusted and reliable partner, as it constantly focuses on understanding their needs to translate these into innovative solutions, helping improve people's lives both physically and emotionally.

Carlos Gallardo, Chairman and CEO of Almirall: "Celebrating 80 years is a testament to Almirall’s enduring commitment to innovation and patient care. Our journey has been driven by a profound dedication to improving patients' lives and providing meaningful treatments. As a family-owned company, we think in generations, and have consistently prioritized innovation in medical dermatology, investing over 1 billion Euros in R&D in this area over the last decade. We are grateful for the dedication of our teams across the company, and our partners and collaborators that enable us to help so many patients, every day. Our leading capabilities in skin biology and product development will continue to be a cornerstone of our mission, ensuring our sustained focus on science and innovation to deliver healthcare solutions to patients and the medical community."

About Almirall

Almirall is a global pharmaceutical company dedicated to medical dermatology. We closely collaborate with leading scientists, healthcare professionals, and patients to deliver our purpose: to transform the patients' world by helping them realize their hopes and dreams for a healthy life. We are at the forefront of science to deliver ground-breaking, differentiated medical dermatology innovations that address patients´ needs.

Almirall, founded in 1944 and headquartered in Barcelona, is publicly traded on the Spanish Stock Exchange (ticker: ALM, total revenue in 2023: €898.8 MM, 1900 employees globally). Almirall products help to improve the lives of patients every day and are available in over 100 countries.

For more information, please visit https://www.almirall.com/

Legal notice:

This document includes only summary information and is not intended to be exhaustive. The facts, figures, and opinions contained in this document, in addition to the historical ones, are "forward-looking statements." These statements are based on the information currently available and the best estimates and assumptions that the Company considers reasonable. These statements involve risks and uncertainties beyond the control of the Company. Therefore, actual results may differ materially from those declared by such forward-looking statements. The Company expressly waives any obligation to revise or update any forward-looking statements, goals, or estimates contained in this document to reflect any changes in the assumptions, events, or circumstances on which such forward-looking statements are based, unless required by the applicable law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241204100180/en/

Contacts

Corporate Communications:
corporate.communication@almirall.com
Phone: (+34) 659 614 173

Investor Relations
investors@almirall.com
Phone: (+34) 93 291 30 87

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

KAYTUS NextGen Servers: Empowering AI Era with Advanced Liquid Cooling5.12.2024 09:02:00 CET | Press Release

KAYTUS, a leading IT infrastructure provider, has announced its new-generation V3 server family, featuring fully optimized liquid cooling technology. These servers provide comprehensive liquid cooling solutions, encompassing components, nodes, servers, and entire data centers. Designed to address cooling challenges and surging energy consumption, the V3 servers enable users to efficiently and reliably meet the demands of the rapidly evolving AI landscape. The surge in AI computing power and density has driven a significant rise in energy consumption. According to the International Energy Agency, electricity usage in data centers is projected to double by 2026 compared to 2022, with approximately 40% of this energy attributed to cooling1. In response, governments are implementing stricter compliance requirements. Starting this year, European data center operators must report key energy consumption metrics annually2 to the European Union (EU), fostering the sustainable development of dat

Manhattan Named a Leader in Point-of-Service and Order Management Analyst Evaluations5.12.2024 09:00:00 CET | Press Release

Manhattan Associates Inc. (NASDAQ: MANH) today announced that it has been named a Leader in The Forrester Wave™: Point-of-Service (POS) Solutions, Q4 2024 report. Of the 9 vendors that were evaluated in the industry’s premier analysis of retail store solutions, Manhattan received the highest score possible in the most number of criteria. Manhattan was recognized for being strong in store inventory management and store fulfillment capabilities, including in-store and curbside pickup. As digital commerce continues to grow, retailers are repurposing their stores to meet the needs of modern shoppers. They are discovering their stores hold the key to sustainable differentiation - not as mere fulfillment points or showrooms, but as sophisticated engines of customer intelligence and relationship building. Modern retail stores are moving beyond selling products and completing checkout transactions to providing a seamless, customer-centric experience that merges the best of digital convenience

Allied Telesis Brings Back Chris Elliott to Lead Global Partner Expansion Strategy5.12.2024 09:00:00 CET | Press Release

Allied Telesis, a global leader in connectivity solutions and intelligent networking tools, announces today that Chris Elliott has rejoined the company as Vice President, Partnerships and Alliances, responsible for executing a strategic partner strategy for company expansion across Asia Pacific, North America, Central America, and EMEA. Elliott is also tasked with managing the Northern European Sales Region including the UK, Nordics, and Benelux. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241205436946/en/ Chris Elliott has rejoined Allied Telesis as Vice President, Partnerships and Alliances (Photo: Business Wire) “I am thrilled to get back in the Allied Telesis family, where I previously held sales management roles from 2016 - 2021. I’m very much aligned with the company’s culture and mission, and I know we are primed for aggressive global expansion. I’m excited to lead the channel team in executing on that growth,” Ell

Telebras and SES implemented more than 1,500 Internet Access Points in Brazil’s Northern Region via SES-175.12.2024 08:50:00 CET | Press Release

Telebras has selected SES, along with other partners, to support the implementation of Brazil’s Electronic Government Program — Citizen Assistance Service (GESAC). The partnership between the companies enabled the implementation of the Managed Enterprise solution across more than 1,500 sites in public institutions, schools, libraries, telecenters, health units, indigenous villages and rural settlements across the country’s Northern Region. As part of SES’s Managed Enterprise solution delivered over its high-throughput SES-17 Ka-band satellite, SES will be responsible for the operation and maintenance of the network, including satellite, gateways and remote sites. The sites have been connected since April 2024 and are supported by SES’s new gateway in Hortolandia, Brazil. SES-17 is a geostationary satellite that offers an optimised solution for accelerating digital inclusion programs across the region, which offers full coverage over Brazil and the rest of Latin America. The GESAC Progr

CRA Selects Netmore Operator Platform-as-a-Service to Deliver Next-Generation LoRaWAN® Connectivity Services in the Czech Republic5.12.2024 08:00:00 CET | Press Release

Netmore Group, a leading global LoRaWAN network operator, today announced that CRA, the largest Czech cloud service provider in the Czech Republic, has chosen Netmore's Operator Platform-as-a-Service (PaaS) to modernize and streamline the delivery of commercial Internet of Things (IoT) services to its customers. Netmore PaaS enables CRA to not only deliver carrier-grade and future-proof LoRaWAN network connectivity, but also optimizes the company’s network monitoring and technical support for IoT deployments across multiple industries and use cases. CRA's IoT portfolio includes a nationwide LoRaWAN network which covers more than 80% of the nation’s population and IoT Cloud, a platform for standardizing the processing and integration of connected device data. CRA’s infrastructure supports a wide range of high-growth use cases that are complementary to Netmore’s focus within the smart metering, water management, environmental monitoring, and building automation segments. Additionally, th

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye